Astapan, Fadzra A.
HRN: 25-41-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
CEFUROXIME 1.5GM (VIAL)
07/02/2024
07/03/2024
IV
1.5grams
3 Cycles
UTI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes